Matsushima et al showed a decreasing trend in bladder weight and levels of pAKT, pS6, and p4EBP1 in the NVP-BEZ235-treated group compared with the control group, suggesting that NVP-BEZ235 exerts a significant antitumor effect by inhibiting the PI3K/AKT/mTOR pathway.
← all excerpts
Prognostic analysis of anoikis-related genes in bladder cancer: An observational study.
1
—
—